ASX - By Stock
|
CGR |
Re:
Ann: Completion of Ground Geophysics Enhances Targets
|
|
Alf107
|
361 |
77K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
361
|
77K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 cGMP Manufacturing Complete
|
|
Alf107
|
76 |
23K |
23 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
76
|
23K
|
23
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
26 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
20K
|
6.9M
|
26
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
3 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.1K
|
388K
|
3
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
2 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
1.1K
|
388K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
4 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
1.1K
|
388K
|
4
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
1.1K
|
388K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Alf107
|
113 |
25K |
2 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
113
|
25K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
20 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
20K
|
6.9M
|
20
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
14 |
29/11/23 |
29/11/23 |
General
|
10K
|
3.7M
|
14
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
42 |
29/11/23 |
29/11/23 |
General
|
10K
|
3.7M
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
Alf107
|
508 |
121K |
6 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
121K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
Alf107
|
226 |
53K |
7 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
53K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
Alf107
|
226 |
53K |
19 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
53K
|
19
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
13 |
22/11/23 |
22/11/23 |
General
|
10K
|
3.7M
|
13
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
2 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
1.1K
|
388K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
2 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
1.1K
|
388K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Alf107
|
231 |
64K |
15 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
64K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Alf107
|
231 |
64K |
7 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
64K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Alf107
|
231 |
64K |
27 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
64K
|
27
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
23 |
07/11/23 |
07/11/23 |
General
|
10K
|
3.7M
|
23
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Alf107
|
2.0K |
668K |
21 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
2.0K
|
668K
|
21
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
4 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
20K
|
6.9M
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
5 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
16 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
20K
|
6.9M
|
16
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
Alf107
|
143 |
51K |
20 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
143
|
51K
|
20
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
5 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
7 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
20K
|
6.9M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
17 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
20K
|
6.9M
|
17
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Alf107
|
438 |
175K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
438
|
175K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Alf107
|
438 |
175K |
3 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
438
|
175K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Alf107
|
438 |
175K |
7 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
438
|
175K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
Alf107
|
592 |
183K |
8 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
592
|
183K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
Alf107
|
592 |
183K |
6 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
592
|
183K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
Alf107
|
592 |
183K |
18 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
592
|
183K
|
18
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.1K
|
388K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
16 |
25/07/23 |
25/07/23 |
General
|
10K
|
3.7M
|
16
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
20K |
6.9M |
8 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
20K
|
6.9M
|
8
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
34 |
19/07/23 |
19/07/23 |
General
|
10K
|
3.7M
|
34
|
|
ASX - By Stock
|
PGO |
Re:
Ann: Broad Zones of Veining within Targeted IP Anomaly
|
|
Alf107
|
47 |
20K |
5 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
47
|
20K
|
5
|
|
ASX - By Stock
|
PGO |
Re:
Ann: Broad Zones of Veining within Targeted IP Anomaly
|
|
Alf107
|
47 |
20K |
2 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
47
|
20K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
$1.40 to 1 cent, can anyone explain why?
|
|
Alf107
|
36 |
13K |
3 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
36
|
13K
|
3
|
|
ASX - By Stock
|
PGO |
Re:
Ann: Broad Zones of Veining within Targeted IP Anomaly
|
|
Alf107
|
47 |
20K |
3 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
47
|
20K
|
3
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
4 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
1.1K
|
388K
|
4
|
|
ASX - By Stock
|
PGO |
Re:
Ann: Broad Zones of Veining within Targeted IP Anomaly
|
|
Alf107
|
47 |
20K |
1 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
47
|
20K
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
27 |
22/06/23 |
22/06/23 |
General
|
10K
|
3.7M
|
27
|
|
ASX - By Stock
|
PGO |
Re:
Ann: Broad Zones of Veining within Targeted IP Anomaly
|
|
Alf107
|
47 |
20K |
1 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
47
|
20K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
388K |
4 |
10/06/23 |
10/06/23 |
ASX - By Stock
|
1.1K
|
388K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Alf107
|
2.0K |
668K |
27 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
2.0K
|
668K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Alf107
|
2.0K |
668K |
10 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
2.0K
|
668K
|
10
|
|